Fuji Pharma Co., Ltd. (TYO:4554)
Japan
· Delayed Price · Currency is JPY 2,297.00
+45.00 (2.00%)
Mar 10, 2026, 1:05 PM JST
Fuji Pharma Ratios and Metrics
Market cap in millions JPY. Fiscal year is October - September.
Millions JPY. Fiscal year is Oct - Sep.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | 2020 - 2016 |
| Market Capitalization | 55,106 | 37,703 | 30,950 | 28,337 | 25,121 | 28,416 | Upgrade
|
| Market Cap Growth | 64.39% | 21.82% | 9.22% | 12.80% | -11.60% | -26.98% | Upgrade
|
| Enterprise Value | 82,185 | 62,378 | 57,137 | 54,046 | 45,919 | 37,050 | Upgrade
|
| Last Close Price | 2252.00 | 1546.00 | 1234.74 | 1097.98 | 943.04 | 1030.82 | Upgrade
|
| PE Ratio | 23.59 | 12.57 | 5.04 | 8.25 | 9.32 | 11.68 | Upgrade
|
| Forward PE | 15.35 | 10.31 | 7.24 | 8.29 | 8.47 | 12.03 | Upgrade
|
| PS Ratio | 1.01 | 0.73 | 0.67 | 0.69 | 0.71 | 0.84 | Upgrade
|
| PB Ratio | 1.15 | 0.80 | 0.68 | 0.69 | 0.70 | 0.87 | Upgrade
|
| P/TBV Ratio | 1.62 | 1.14 | 0.94 | 0.92 | 0.99 | 0.94 | Upgrade
|
| P/FCF Ratio | - | 9.87 | 22.54 | - | - | 12.89 | Upgrade
|
| P/OCF Ratio | - | 6.50 | 7.46 | 14.78 | - | 4.74 | Upgrade
|
| PEG Ratio | - | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 | Upgrade
|
| EV/Sales Ratio | 1.51 | 1.21 | 1.24 | 1.32 | 1.30 | 1.09 | Upgrade
|
| EV/EBITDA Ratio | 7.78 | 6.97 | 7.56 | 7.85 | 7.04 | 6.79 | Upgrade
|
| EV/EBIT Ratio | 12.59 | 12.50 | 14.72 | 14.01 | 12.15 | 11.06 | Upgrade
|
| EV/FCF Ratio | - | 16.33 | 41.61 | - | - | 16.81 | Upgrade
|
| Debt / Equity Ratio | 0.64 | 0.66 | 0.64 | 0.70 | 0.69 | 0.57 | Upgrade
|
| Debt / EBITDA Ratio | 2.88 | 3.45 | 3.87 | 4.21 | 3.77 | 3.42 | Upgrade
|
| Debt / FCF Ratio | - | 8.10 | 21.31 | - | - | 8.47 | Upgrade
|
| Net Debt / Equity Ratio | 0.56 | 0.51 | 0.54 | 0.65 | 0.59 | 0.26 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.56 | 2.65 | 3.26 | 3.87 | 3.22 | 1.55 | Upgrade
|
| Net Debt / FCF Ratio | - | 6.20 | 17.97 | -18.88 | -3.65 | 3.84 | Upgrade
|
| Asset Turnover | 0.58 | 0.56 | 0.53 | 0.51 | 0.51 | 0.54 | Upgrade
|
| Inventory Turnover | 1.49 | 1.58 | 1.51 | 1.39 | 1.50 | 1.70 | Upgrade
|
| Quick Ratio | 0.83 | 0.82 | 0.66 | 0.63 | 0.68 | 1.10 | Upgrade
|
| Current Ratio | 1.57 | 1.55 | 1.19 | 1.31 | 1.45 | 1.73 | Upgrade
|
| Return on Equity (ROE) | 4.88% | 6.49% | 14.17% | 8.92% | 7.87% | 6.70% | Upgrade
|
| Return on Assets (ROA) | 4.31% | 3.40% | 2.77% | 3.00% | 3.38% | 3.32% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.41% | 5.32% | 4.18% | 4.84% | 5.59% | 5.95% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.40% | 8.00% | 7.20% | 6.90% | 7.30% | 7.60% | Upgrade
|
| Earnings Yield | 4.23% | 7.96% | 19.86% | 12.12% | 10.73% | 8.56% | Upgrade
|
| FCF Yield | - | 10.13% | 4.44% | -4.98% | -22.91% | 7.76% | Upgrade
|
| Dividend Yield | 2.00% | 2.94% | 3.44% | 3.37% | 3.71% | 2.81% | Upgrade
|
| Payout Ratio | - | 34.53% | 15.82% | 26.17% | 27.04% | 33.18% | Upgrade
|
| Buyback Yield / Dilution | -0.50% | -0.38% | -0.04% | -0.03% | 9.58% | 13.77% | Upgrade
|
| Total Shareholder Return | 1.50% | 2.56% | 3.40% | 3.34% | 13.29% | 16.58% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.